Line 85: | Line 85: | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
− | <td><b> | + | <td><b>Validated Part / Validated Contribution</b></td> |
− | <td>We | + | <td>We created a new BioBrick part as expected : #nameofthepart. This part is #descriptionofthepart.</td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
− | <td><b> | + | <td><b> Collaboration </b</td> |
− | <td>We | + | <td> |
− | + | We hosted the 4th Parisian Meet-Up where we organised a Tiny Jamboree in order to practice with all the French teams for the Giant. We also attended round tables about bioethics.</br> | |
− | + | We collaborated with other teams, you can read about them on this <a href="https://2018.igem.org/Team:Pasteur_Paris/Collaboration#igemers" style="font-weight: bold ; color:black; text-decoration:none;" target="_blank"> page</a>.</br> | |
− | + | </td> | |
− | + | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
− | <td><b> | + | <td><b>Human Practices</b</td> |
− | <td> | + | <td> |
+ | <li>Ethics and safety: </br> | ||
+ | <li>Security: The Institut Pasteur is a highly restricted area so we had ID badges to enter every building and unity. + substances we used</br> | ||
+ | <li>Sustainability: ? Kill switch ? </br> | ||
+ | <li>Social justice: ? </br> | ||
+ | <li>Intellectual property rights: account of state of the art, no infrigement of IP laws. </br> | ||
+ | </td> | ||
</tr> | </tr> | ||
</table> | </table> | ||
Line 119: | Line 124: | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
− | <td><b> | + | <td><b>Integrated Human Practices</b></td> |
− | <td>We | + | <td>We created a new BioBrick part as expected : #nameofthepart. This part is #descriptionofthepart</td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
− | <td><b> | + | <td><b>Improve a Previous Part or Project</b</td> |
<td>We plane to make the competition deliverables met on time.</td> | <td>We plane to make the competition deliverables met on time.</td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
− | <td><b> | + | <td><b>Model Your Project</b</td> |
− | <td>We | + | <td>We modelled how NGF is produced in our modified E. Coli, its diffusion in an environment and its consequences on neurons growth. It helped to predict how to use NGF in our experiments.</td> |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
</tr> | </tr> | ||
</table> | </table> |
Revision as of 00:30, 5 October 2018
Bronze medal criterias
Explanation | Criteria achieved |
Registration and Giant Jamboree Attendance | We registered for iGEM then had a great summer time and are now waiting to attend the Giant Jamboree. |
Competition Deliverables | We plane to make the competition deliverables met on time. |
Attributions | We completed the attributions page on our wiki. |
Characterization / Contribution | We successfully completed the InterLab Measurement Study. |
Silver medal criterias
Explanation | Criteria achieved |
Validated Part / Validated Contribution | We created a new BioBrick part as expected : #nameofthepart. This part is #descriptionofthepart. |
Collaboration | We hosted the 4th Parisian Meet-Up where we organised a Tiny Jamboree in order to practice with all the French teams for the Giant. We also attended round tables about bioethics. We collaborated with other teams, you can read about them on this page. |
Human Practices |
|
Gold medal criterias
Explanation | Criteria achieved |
Integrated Human Practices | We created a new BioBrick part as expected : #nameofthepart. This part is #descriptionofthepart |
Improve a Previous Part or Project | We plane to make the competition deliverables met on time. |
Model Your Project | We modelled how NGF is produced in our modified E. Coli, its diffusion in an environment and its consequences on neurons growth. It helped to predict how to use NGF in our experiments. |